Low-Level Rifampin Resistance and rpoB Mutations in Mycobacterium tuberculosis: an Analysis of Whole-Genome Sequencing and Drug Susceptibility Test Data in New York

Author:

Shea Joseph1,Halse Tanya A.1,Kohlerschmidt Donna1,Lapierre Pascal1ORCID,Modestil Herns A.2,Kearns Cheryl H.3,Dworkin Felicia F.2,Rakeman Jennifer L.4ORCID,Escuyer Vincent1,Musser Kimberlee A.1ORCID

Affiliation:

1. Wadsworth Center, New York State Department of Health, Albany, New York, USA

2. New York City Department of Health and Mental Hygiene, New York, New York, USA

3. New York State Department of Health, Albany, New York, USA

4. Public Health Laboratory, New York City Department of Health and Mental Hygiene, New York, New York, USA

Abstract

Rapid and reliable detection of rifampin (RIF) resistance is critical for the diagnosis and treatment of drug-resistant and multidrug-resistant (MDR) tuberculosis. Discordant RIF phenotype/genotype susceptibility results remain a challenge due to the presence of rpoB mutations that do not confer high levels of RIF resistance, as have been exhibited in strains with mutations such as Ser450Leu.

Funder

Association of Public Health Laboratories

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3